| Market Cap | ₹355Cr |
| ROE | 2.62% |
| P/E Ratio(TTM) | 54.01 |
| EPS(TTM) | 1.35 |
| P/B Ratio | 1.41 |
| Dividend Yield | 0.00% |
| Industry P/E | 32.93 |
| Book Value | 51.57 |
| Debt to Equity | 0.48 |
| Face Value | 10 |
| Parent Organisation | Zim Laboratories Limited. |
| Managing Director | Dr. Chandrashekhar Mainde |
| Founded | 1989 |
| NSE Symbol | ZIMLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.18 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.75 | ||
| Wockhardt | NA (0.00%) | -421.02 | ||
| Cohance Lifesciences | NA (0.00%) | 65.35 |